Featured Publications
About Our Research
We’ve doubled down on our commitment to research and teaching.
Arkana is a learning, teaching, and innovating practice with one unifying passion – to actively work toward the day that our research yields breakthroughs that make our services unnecessary. Eradicating rare and common diseases is the end game of all of our efforts because patient health is foremost in our minds every day. Read about some of our latest publications below.
All Publications
(475 Results)
-
Statin Therapy Is Associated With Reduced Neuropathologic Changes Of Alzheimer Disease
Treatment with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors (“statins”) has been associated in some epidemiologic studies with reduced risk of Alzheimer disease (AD).
Read on PubMed• August 2007
-
Biomarkers For Alzheimer’s Disease
The development and validation of biomarkers for the latent, prodromal and dementia stages of Alzheimer’s disease (AD) is a pressing…
Read on PubMed• August 2007
-
Washington Statewide Pathology Surveillance For Prion Disease
In February 2004, we initiated an epidemiological investigation within a US state to enhance autopsy surveillance for clinically suspected prion…
Read on PubMed• April 2007
-
Engaging In Paced Mating, But Neither Exploratory, Anti-Anxiety, Nor Social Behavior, Increases 5alpha-Reduced Progestin Concentrations In Midbrain, Hippocampus, Striatum, And Cortex
Sequential actions of 17beta-estradiol (E(2)) and progesterone (P(4)) in the hypothalamus and the P(4) metabolite, 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP), in the midbrain…
Read on PubMed• March 2007